Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
2023 · Journal of the National Comprehensive Cancer Network · 516 citations
https://doi.org/10.6004/jnccn.2023.0006
R
Rebecca C. Arend
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
416
Papers
6.5K
Citations
44
h-index
90
i10-index
Rebecca C. Arend is an academic researcher from University of Colorado Cancer Center. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & Cancer Genomics and Diagnostics. The author has an h-index of 44, co-authored 354 publications.
ORCID: 0000-0003-2108-3426Papers by this author
worksHomologous Recombination Deficiency: Concepts, Definitions, and Assays
2022 · The Oncologist · 207 citations
https://doi.org/10.1093/oncolo/oyab053
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
2022 · The Lancet Oncology · 136 citations
https://doi.org/10.1016/s1470-2045(22)00139-5
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
2018 · Molecular Cancer Research · 59 citations
https://doi.org/10.1158/1541-7786.mcr-17-0594
Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey
2021 · Gynecologic Oncology Reports · 21 citations
https://doi.org/10.1016/j.gore.2021.100871
Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data
2021 · Advances in Therapy · 17 citations
https://doi.org/10.1007/s12325-021-01959-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat